Over the past 12 months, 0 insiders at Syros Pharmaceuticals, Inc. filed 0 open-market SEC Form 4 transactions on SYRS: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 2, 24 | Nancy A SimonianDirector | SELL | 37.1K | $0.27 | $10K |
| Nov 25, 24 | Nancy A SimonianDirector | SELL | 134.7K | $0.27 | $36K |
| Nov 19, 24 | Gerald E QuirkChief Legal & Compliance Offic | SELL | 46.7K | $0.22 | $10K |
| Nov 18, 24 | Conley CheePresident & CEO | SELL | 134.8K | $0.20 | $27K |
| Nov 18, 24 | Jason HaasChief Financial Officer | SELL | 137.8K | $0.21 | $29K |
| Nov 18, 24 | David RothChief Medical Officer | SELL | 12.1K | $0.20 | $2K |
| Nov 18, 24 | Kristin StephensChief Development Officer | SELL | 36.1K | $0.22 | $8K |
| Sep 12, 24 | Jason HaasChief Financial Officer | BUY | 45.3K | $1.68 | $76K |
| Sep 11, 24 | Conley CheePresident & CEO | BUY | 50.0K | $1.71 | $86K |
| Sep 11, 24 | Jason HaasChief Financial Officer | BUY | 19.3K | $1.58 | $30K |
| Sep 10, 24 | Conley CheePresident & CEO | BUY | 50.0K | $1.51 | $76K |
| Sep 10, 24 | Jason HaasChief Financial Officer | BUY | 35.4K | $1.55 | $55K |
| Jun 28, 24 | Richard A YoungDirector | SELL | 34.8K | $5.12 | $178K |
| Apr 3, 24 | David RothChief Medical Officer | SELL | 10.5K | $4.95 | $52K |
| Apr 2, 24 | David RothChief Medical Officer | SELL | 150 | $4.98 | $747 |
| Dec 21, 23 | Srinivas AkkarajuDirector | BUY | 905.0K | $4.42 | $4.0M |
| Dec 12, 23 | David RothChief Medical Officer | SELL | 6.3K | $4.95 | $31K |
| Dec 6, 23 | David RothChief Medical Officer | SELL | 6.3K | $3.95 | $25K |
| Jul 31, 23 | David RothChief Medical Officer | SELL | 7.3K | $3.95 | $29K |
| Jul 17, 23 | Eric R OlsonChief Scientific Officer | SELL | 689 | $3.50 | $2K |
| Sep 30, 22 | Timothy TysonDirector | BUY | 14.0K | $6.37 | $89K |
| Sep 29, 22 | Timothy TysonDirector | BUY | 2.9K | $5.72 | $17K |
| Jan 5, 22 | Eric R OlsonChief Scientific Officer | SELL | 2.2K | $3.47 | $8K |
Over the past 12 months, insiders at Syros Pharmaceuticals, Inc. filed 0 open-market purchases worth $0 and 0 sales worth $0 on SYRS, which makes them mixed over the period. The most recent Form 4 was filed on .
The largest recent open-market SYRS insider purchase in our data was $4.0M by Srinivas Akkaraju, Director, filed on Dec 21, 23.
0 different insiders at Syros Pharmaceuticals, Inc. filed open-market SEC Form 4 transactions on SYRS over the last 12 months.
InsiderTape plots every SYRS insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Syros Pharmaceuticals, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →